| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/20/2002 | US6436965 Inhibition of phosphodiesterase; 3-carbocyclic(alkyl)oxy-2-aryl(alkyl)aminocarbonyl-1-aryl(alkyl)indole or azaindole derivatives |
| 08/20/2002 | US6436964 Piperidine derivatives having effects on serotonin related systems |
| 08/20/2002 | US6436960 Farnesyl transferase inhibitors having a piperidine structure and process for preparation thereof |
| 08/20/2002 | US6436958 Inhibition of t cell function and class ii antigen expression thereby inhibiting macrophage mediated antigen presentation, and/or inhibition of release of il-1, tnf cytokines, and other inflammatory mediators; 2-phenyl-3-aroylbenzothiophenes |
| 08/20/2002 | US6436957 Indole derivatives as 5-HT1 agonists |
| 08/20/2002 | US6436956 Less hygroscopic antidepressant |
| 08/20/2002 | US6436955 Storage stable, less hygroscopic, bactericide |
| 08/20/2002 | US6436954 Benzo(b)quinolizidine and benzo(f)indolizidine derivatives useful for the treatment of alzheimer's disease, senile dementia or other conditions characterized by memory loss; pyrrolo(1,2-b)isoquinolines, benzo(b)quinolizines |
| 08/20/2002 | US6436953 Antisecretory agents, gastrointestinal inflammatory diseases; (7r,8r,9r)-2,3-dimethyl-8-hydroxy-7-methoxy-9-phenyl-7,8,9,10-tetrahydro -imidazo(1,2-h)-(1,7)naphthyridine |
| 08/20/2002 | US6436952 Cyclic nucleotide phosphodiesterase inhibitors; inflammatory airway disorders, such as asthma; antiinflammatory; 6-(4-(2h-2-ethyltetrazol-5-yl) phenyl)-1,2,3,4,4a,10b-hexahydrobenzo(c)(1,6)naohthyridine n-2-oxides |
| 08/20/2002 | US6436951 Camptothecin tetracyclic analogues, preparation, method, applications as medicines and pharmaceutical compositions containing them |
| 08/20/2002 | US6436950 Effective for the amelioration of erectile dysfunction in a mammal without causing substantial intolerable adverse side effects; sodium metabisulfite, ascorbic acid, or sodium ascorbate reducing agent |
| 08/20/2002 | US6436949 Heterocyclically substituted benzamides and their use |
| 08/20/2002 | US6436948 And other hyperproliferative keratinocyte diseases such as hyperkeratosis, ichthyosis, keratoderma or lichen planus; anticancer, antitumor; prodrug forms of (-)-(2s,4s)-1-(2-hydroxymethyl-1,3-dioxolan-4-yl)cytosine |
| 08/20/2002 | US6436946 Xanthine-containing compositions for oral administration and uses related thereto |
| 08/20/2002 | US6436945 Substituted O6-benzyl-8-aza-guanines |
| 08/20/2002 | US6436944 Combination effective for the treatment of impotence |
| 08/20/2002 | US6436943 Use of dihydropyrimidines as medicaments, and novel substances |
| 08/20/2002 | US6436942 Enantiomers of 1[(4-chloro-phenyl) phenylmethyl]-4-[(4-methylphenyl) sulfony]piperazine |
| 08/20/2002 | US6436941 Treating schizophrenia, depression, and parkinson's disease; side effect reduction |
| 08/20/2002 | US6436939 Treatment of central nervous system disorders including sleep/wake disorders, dementia, alzheimer's disease, epilepsy, narcolepsy, eating disorders, motion sickness, vertigo |
| 08/20/2002 | US6436938 Combination treatment for depression |
| 08/20/2002 | US6436937 Use of desoxypeganine in the treatment of Alzheimer's dementia |
| 08/20/2002 | US6436936 Epilepsy |
| 08/20/2002 | US6436935 Paste with polyacrylic acid |
| 08/20/2002 | US6436933 Inhibitors of anthrax lethal factor activity |
| 08/20/2002 | US6436932 Psychiatric disorders and neurological diseases; corticotropin releasing factor; pyrrolo(2,3-d)pyrimidine derivatives |
| 08/20/2002 | US6436931 Cytotoxic agents comprising taxanes and their therapeutic use |
| 08/20/2002 | US6436929 Cyclothiocarbamate derivatives as progesterone receptor modulators |
| 08/20/2002 | US6436926 Topically applying taurolidine, as an active ingredient |
| 08/20/2002 | US6436925 Better able to cross membranes; inhibitors of cysteine proteases like calpain i and ii and cathepsin b and l, can thus be used to control diseases associated with an elevated activity of calpain enzymes or cathepsin enzymes |
| 08/20/2002 | US6436924 Useful for treating allergic rhinitis, vasomotor rhinitis and allergic conjunctivitis; nonsedating antihistamines or salts, leukotriene d4 antagonist or 5-lipoxygenase inhibitor or flap protein antagonist |
| 08/20/2002 | US6436923 Compounds and methods for modulation of estrogen receptors |
| 08/20/2002 | US6436921 Have low minimum inhibitory concentrations for grampositive and gramnegative strains, are stable against degradation by renal dehydropeptidase-i and have excellent bioavailability |
| 08/20/2002 | US6436920 An antiwrinkle and antiaging agent (cosmetic skin care agent) comprising a guanidine derivative |
| 08/20/2002 | US6436916 Phenolic esters of ibuprofen with salicylic acid or its nontoxic salts used as antitumor agent |
| 08/20/2002 | US6436915 Antiproliferative and antitumor agents and angiogenesis inhibitors |
| 08/20/2002 | US6436913 Use of estramustine phosphate in the treatment of bone metastasis |
| 08/20/2002 | US6436911 IL-12 production inhibitor |
| 08/20/2002 | US6436910 Method of promoting mucosal hydration with certain uridine, adenine and cytidine diphosphates and analogs thereof |
| 08/20/2002 | US6436909 Antisense inhibition of transforming growth factor-β expression |
| 08/20/2002 | US6436908 Administering to cardiac muscle of mammal via cardiac perfusion expression vector comprising promoter active in myocardium operably linked to dna sequence encoding beta adrenergic receptor kinase 1 inhibitor |
| 08/20/2002 | US6436907 Adenovirus-medicated gene transfer to cardiac and vascular smooth muscle |
| 08/20/2002 | US6436906 Novel macrolides having antibacterial activity toward grampositive and gramnegative bacteria as well as macrolide resistant grampositives |
| 08/20/2002 | US6436903 Immunomodulating compounds comprising d-isomers of amino acids |
| 08/20/2002 | US6436899 Nutritional intervention composition for enhancing and extending satiety |
| 08/20/2002 | US6436691 Chemical compounds |
| 08/20/2002 | US6436679 Process for the preparation of immunodulatory polysaccharides from aloe |
| 08/20/2002 | US6436670 Gene and uses therefor |
| 08/20/2002 | US6436629 Modulating angiogenesis |
| 08/20/2002 | US6436448 Treating lymphedema and for inducing weight-loss, guaifenesin |
| 08/20/2002 | US6436444 Acidic aqueous chlorite teat dip providing shelf life sanitizing capacity and tissue protection |
| 08/20/2002 | US6436443 Porous particles comprising excipients for deep lung delivery |
| 08/20/2002 | US6436438 Tramadol multiple unit formulations |
| 08/20/2002 | US6436437 Covalent polar lipid conjugates with neurologically active compounds for targeting |
| 08/20/2002 | US6436435 Liposome formulation of 5 β steroids |
| 08/20/2002 | US6436431 Fortified rice bran food product and method for promoting cardiovascular health |
| 08/20/2002 | US6436430 Self-emulsifying compositions for drugs poorly soluble in water |
| 08/20/2002 | US6436429 Process and composition for temporarily suppressing pain |
| 08/20/2002 | US6436428 Device and method for treating urinary incontinence in females |
| 08/20/2002 | US6436425 Administering aqueous formulation comprising polyoxyalkylene block cpolymer and water to tissues of mammal for inhibiting the formation/reformation of internal adhesions |
| 08/20/2002 | US6436414 Active ingredient combinations or adducts of biotin and/or biotin derivatives and cyclodextrins and use of such active ingredient combinations in cosmetic preparations |
| 08/20/2002 | US6436410 DNA encoding neospora dihydrofolate reductase-thymidylate synthase |
| 08/20/2002 | US6436406 Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides and atherosclerosis |
| 08/20/2002 | US6436398 Administering a beta-lactam antibiotic with a beta-lactamase inhibiting compound such as benzhydryl 2-beta-(chloroacetoxy-methyl)-6-((z)-(tert-butoxycarbonyl)methylene) penicillinate to treat beta-lactam resistant bacterial infections |
| 08/20/2002 | US6436397 Reducing autodegradation during processing and purification. lyophilized solutioni with bulking agent, sucrose, trehalose, or raffinose |
| 08/20/2002 | US6436392 Dna segment confers increased episomal stability, persistence or abundance of the isolated dna molecule in a host cell |
| 08/20/2002 | US6436386 Hydroxyapatite-targeting poly (ethylene glycol) and related polymers |
| 08/20/2002 | US6436385 Trimethylglycine compound |
| 08/20/2002 | US6436378 Skin lightener, herbal extract complex (biowhite); mixture of sodium ascorbyl phosphate, niacinamide, complex of aspergillus ferment and licorice (gatuline); octylmethoxycinnamate and benzophenone or methylene bisbenzotriazolyl tetramethylbu |
| 08/20/2002 | US6436376 Enhanced SPF UV-sunscreen/tricontanyl PVP photoprotecting (sprayable) formulations |
| 08/20/2002 | US6436371 Oral composition |
| 08/20/2002 | US6436369 Anti-plaque emulsions and products containing same |
| 08/20/2002 | US6436368 Process for preparing beclomethasone dipropionate freon® clathrate |
| 08/20/2002 | US6436366 Detecton, treatment and monitoring the patient with poor wound healing ability due to diabetes based on measurement of the breakdown product of nitric oxide (no) in specimens taken from the patient under controlled conditions |
| 08/20/2002 | US6436344 Method of inactivating pathogens |
| 08/20/2002 | US6435873 Medication delivery devices |
| 08/20/2002 | US6435249 Method of recycling disk recording medium and apparatus for recovering metal reflective film |
| 08/20/2002 | CA2335397C A method for screening compounds for their potential to inhibit neoplasia and pharmaceutical compositions containing such compounds |
| 08/20/2002 | CA2291072C Method for the preparation of citalopram |
| 08/20/2002 | CA2266183C Herbal composition for treatment of bronchitis and respiratory disorders with anti cancer properties and process for preparing same |
| 08/20/2002 | CA2257222C Amide derivatives |
| 08/20/2002 | CA2255663C Antifungal composition with enhanced bioavailability |
| 08/20/2002 | CA2252895C Mesylate trihydrate salt of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2(1h)-indol-2-one (=ziprasidone), its preparation and its use as dopamine d2 antagonist |
| 08/20/2002 | CA2250263C Human netrin-1 |
| 08/20/2002 | CA2240138C Quinazolin-4-one ampa antagonists |
| 08/20/2002 | CA2238283C Method for identifying compounds for inhibition of neoplastic lesions, pharmaceutical compositions from such compounds and uses of such compounds and compositions for treating neoplastic lesions |
| 08/20/2002 | CA2216129C Lactam-containing hydroxamic acids |
| 08/20/2002 | CA2210353C Stabilized external guide sequences |
| 08/20/2002 | CA2203991C Methods and devices for immunizing a host to tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides |
| 08/20/2002 | CA2203463C New diosmetin acids and esters, and the pharmaceutical compounds that contain them |
| 08/20/2002 | CA2180378C Forms a and b of n-[[[2-[[[2-[(diaminomethylene)amino]-4-thiazolyl]methyl]thio]ethyl]amino]methylene]-4-bromo-benzenesulfonamide |
| 08/20/2002 | CA2164321C Plasma-like solution |
| 08/20/2002 | CA2150372C Stable oral ci-981 formulation and process of preparing same |
| 08/20/2002 | CA2145664C Oligonucleotides having a conserved g4 core sequence |
| 08/20/2002 | CA2077695C Hydropyridine derivatives having antithrombotic activity |
| 08/20/2002 | CA2073983C Novel vitamin d analogues |
| 08/20/2002 | CA2072366C carboxylic acid-metal ion-acid complexes |
| 08/20/2002 | CA2071273C Tetrahydropyrrolo[1,2-a]pyrazine-4-spiro-3'-pyrrolidine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same |
| 08/20/2002 | CA2070114C A method of treating hyperglycemia |